Zuoli Pharmaceutical: intends to issue convertible corporate bonds to raise funds of no more than RMB 1.556 billion.

ZALI Pharmaceutical announced that the company plans to issue convertible corporate bonds to non-specific investors to raise funds of no more than RMB 1.556 billion. The net proceeds after deducting issuance expenses are intended to be used for the intelligent traditional Chinese medicine health factory, the "Wuling+X" product development project, and supplementary working capital.